Carregant...
T(H)2-cell targeted pulmonary siRNA delivery for the treatment of asthma
Despite the large number of drugs available for the treatment of asthma, in 5-10% of the patients this disease is not well controlled. While most treatments palliate symptoms, those suffering from severe and uncontrolled asthma could benefit more from a therapeutic approach addressing the root probl...
Guardat en:
| Publicat a: | Wiley Interdiscip Rev Nanomed Nanobiotechnol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7116616/ https://ncbi.nlm.nih.gov/pubmed/32267622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/wnan.1634 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|